Publications by authors named "G D Boorgula"

Claim this Profile
E
Eravacycline pharmacokinetics/pharmacodynamics in the hollow fiber system model of lung disease.
Sanjay Singh, Avneesh Shrivastava, Gunavanthi D Boorgula, Mary C Long, Brian Robbins

Microbiol Spectr· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical pharmacokinetics/pharmacodynamics studies defining the role of ethambutol in lung disease.
Tawanda Gumbo, Gunavanthi D Boorgula, Shashikant Srivastava

Antimicrob Agents Chemother· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical evaluation of epetraborole in the hollow fibre system model of Mycobacterium abscessus lung disease.
Sanjay Singh, Gunavanthi D Boorgula, Minh-Vu H Nguyen, Charles L Daley, Tawanda Gumbo

J Antimicrob Chemother· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sulbactam-durlobactam improves cephalosporin and carbapenem susceptibility and time-kill effect against .
Avneesh Shrivastava, Gunavanthi D Boorgula, Sanjay Singh, Danaleigh Stiles, Pamela J McShane

Microbiol Spectr· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mycobacteria susceptibility to epetraborole: how far can it go?
S Singh, G D Boorgula, R-A Galvez, S K Heysell, P J McShane

Int J Tuberc Lung Dis· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis